NOVUS HOLDINGS LIMITED - Exercise of Share Options and Sale of Shares in terms of the Novus Holdings Share Appreciation Rights Scheme

Exercise of Share Options and Sale of Shares in terms of the Novus Holdings Share Appreciation Rights Scheme

Novus Holdings Limited
Incorporated in the Republic of South Africa
(Registration number 2008/011165/06)
JSE share code: NVS   ISIN: ZAE000202149
("Novus" or "the Company")


EXERCISE OF SHARE OPTIONS AND SALE OF SHARES IN TERMS OF THE NOVUS HOLDINGS
SHARE APPRECIATION RIGHTS SCHEME


In compliance with paragraphs 3.63 to 3.74 (both inclusive) of the Listings Requirements of the JSE
Limited, shareholders are notified of the following dealings in securities by directors of the Company
in respect of the Novus Holdings Limited Share Appreciation Rights Plan ("SAR Plan").

In terms of the SAR Plan, on the SAR exercise date, the appreciation in each SAR is calculated by
deducting the grant price from the exercise price ("Appreciation Value"). The deemed exercise price is
the market price of a Novus share at the exercise date. Following the exercise of the SAR, the participant
receives Novus shares from the Company equal to the Appreciation Value.

Director:                             Craig Wright
Company:                              Novus Holdings Limited
Class of securities:                  Ordinary shares of no par value
Nature of interest:                   Direct beneficial
Clearance to deal obtained:           Yes

Nature of transaction:                Off-market exercise of SARs
Number of SAR awards:                 44 023                 137 806                 225 896
Grant price:                          R2.40                  R4.00                   R4.12
Date of award:                        20 December 2019       26 July 2019            13 July 2018
Exercise date:                        28 June 2024           28 June 2024            28 June 2024
Number of Novus shares received       25 088                 39 020                  59 105
on exercise:
Deemed exercise price:                R5.58                  R5.58                   R5.58
Total value of transaction:           R139 991.04            R217 731.60             R329 805.90

Nature of the transaction:            Sale of shares on market to settle tax liability arising from
                                      exercising of SARs
Date of transaction:                  28 June 2024
Number of securities:                 55 833
Volume weighted average price         R5.6035
per security:
Lowest price:                         R5.60
Highest price:                        R5.61
Total value:                          R312 860.22


Director:                             Keshree Alwar
Company:                              Novus Holdings Limited
Class of securities:                  Ordinary shares of no par value
Nature of interest:                   Direct beneficial
Clearance to deal obtained:           Yes

Nature of transaction:                Off-market exercise of SARs
Number of SAR awards:                 213 863
Grant price:                          R4.12
Date of award:                        13 July 2018
Exercise date:                        1 July 2024
Number of Novus shares received       60 892
on exercise:
Deemed exercise price:                R5.76
Total value of transaction:           R350 737.92

Nature of the transaction:            Sale of shares on market to settle tax liability arising from
                                      exercising of SARs
Date of transaction:                  2 July 2024
Number of securities:                 27 587
Volume weighted average price         R5.8168
per security:
Lowest price:                         R5.80
Highest price:                        R5.85
Total value:                          R160 468.06


Cape Town
4 July 2024

Sponsor
Merchantec Capital

Date: 04-07-2024 04:53:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.